Review of current therapies for secondary hypertrophic pulmonary osteoarthropathy

Keyphrases

• Current Therapies 100%
• Treatment Modalities 33%
• Bisphosphonates 16%
• Treatment Options 16%
• Resection 16%
• Non-steroidal Anti-inflammatory Drugs (NSAIDs) 16%
• Randomized Controlled Trial 16%
• Arthritis 16%
• Clinical Diagnosis 16%
• Pathogenic Mechanism 16%
• Arthralgia 16%
• Analgesic 16%
• Vagotomy 16%
• PubMed Database 16%
• Octreotide 16%
• Disabling Conditions 16%
• Pathophysiological Mechanisms 16%
• Infection Treatment 16%
• Primary Therapy 16%
• Direct Therapy 16%
• Radiotherapy Treatment 16%
• Tumor Chemotherapy 16%
• Primary Lung Cancer 16%
• Periostitis 16%

Medicine and Dentistry

• Osteoarthropathy 100%
• Infection 16%
• Symptomatic Treatment 16%
• Nonsteroid Antiinflammatory Agent 16%
• Lung Cancer 16%
• Randomized Controlled Trial 16%
• Arthritis 16%
• Bisphosphonate 16%
• Octreotide 16%
• Cancer Chemotherapy 16%
• Arthralgia 16%
• Vagotomy 16%
• Surgery 16%
• Radiation Therapy 16%
• Analgesic 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Osteoarthropathy 100%
• Hypertrophic Osteoarthropathy 100%
• Digital Clubbing 16%